Overactive Bladder. [Review] 

 -  2016 
<br/><br/>Available online from MWHC library: 1996 - present 
<br/><br/> Overactive bladder (OAB) is a condition affecting millions of individuals in the United States. Anticholinergics are the mainstay of treatment. Bladder botulinum toxin injections have shown an improvement in symptoms of OAB equivalent to anticholinergic therapy. Percutaneous tibial nerve stimulation can decrease symptoms of urinary frequency and urge incontinence. Sacral neuromodulation for refractory patients has been approved by the Food and Drug Administration for treatment of OAB, urge incontinence, and urinary retention. Few randomized, head-to-head comparisons of the different available alternatives exist; however, patients now have increasing options to manage their symptoms and improve their quality of life. Copyright © 2016 Elsevier Inc. All rights reserved. 
<br/><br/><br/>English 
<br/><br/><label>ISSN: </label>0889-8545 
<br/><br/><label>Subjects--Topical Terms: </label><br/>*Urinary Bladder, Overactive/th [Therapy]<br/>Botulinum Toxins, Type A/tu [Therapeutic Use]<br/>Cholinergic Antagonists/tu [Therapeutic Use]<br/>Electric Stimulation Therapy<br/>Female<br/>Humans<br/>Neuromuscular Agents/tu [Therapeutic Use]<br/>Physical Therapy Modalities<br/>Urinary Bladder, Overactive/di [Diagnosis]<br/>Urinary Bladder, Overactive/et [Etiology]
<br/><br/><label>Subjects--Geographic Terms: </label><br/>MedStar Washington Hospital Center
<br/><br/><label>Index Terms--Occupation: </label><br/>Obstetrics and Gynecology/Female Pelvic Medicine and Reconstructive Surgery
<br/><br/><label>Index Terms--Function: </label><br/>Journal Article<br/>Review